MyMD Pharmaceuticals® Investment Company Oravax Medical and Genomma Lab[...]
MyMD Pharmaceuticals® Announces Positive Clinical Data in Advance of[...]
MyMD Pharmaceuticals® Enrolls First Patient in Phase 2 Clinical Trial[...]
01/18/2022 | News release | Distributed by Public on 01/17/2022 23:40
Please select the service you want to use:
Smartlinks | SS&C Technologies Holdings Inc. | News | Technology | Local News | Jobs and Labor | Company News | Information Technology | Software | Public Companies | Software Companies | London Stock Exchange (LSE) | Börse Frankfurt | Bolsa de Valores de São Paulo (B3) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | BX Swiss | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago | Bolsa Institucional de Valores (BIVA)
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact